Severe Mycoplasma Pneumoniae Infection in Children Admitted to Pediatric Intensive Care.

Abstract

Mycoplasma pneumoniae is a common cause of community-acquired pneumonia and may cause life-threatening disease in children. We identified 30 (0.3%) confirmed M. pneumoniae cases by clinical and laboratory criteria in 11,526 pediatric intensive care unit admissions. Outcomes were comparable to patients admitted with other infections (n=3005; P > 0.1). Our findings indicate that empiric antimicrobial coverage for M. pneumoniae infection in pediatric intensive care unit is rarely needed.

• Authors: Katie M Moynihan, Andrew Barlow, Clare Nourse, Claire Heney, Sanmarié Schlebusch, Luregn J Schlapbach
• Journal: The Pediatric infectious disease journal (Pediatr Infect Dis J) Vol. 37 Issue 12 Pg. e336-e338 (12 2018) ISSN: 1532-0987 [Electronic] United States
• PMID: 29912842 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Bacterial Agents

Topics

• Anti-Bacterial Agents (therapeutic use)
• Australia (epidemiology)
• Child
• Child, Preschool
• Community-Acquired Infections (drug therapy, epidemiology, microbiology)
• Female
• Humans
• Incidence
• Infant
• Intensive Care Units, Pediatric (statistics & numerical data)
• Male
• Mycoplasma pneumoniae
• Pneumonia, Mycoplasma (drug therapy, epidemiology)
• Retrospective Studies